Many patients modifying medication dosage forms without professional advice
the ONA take:
According to a new study published in the Journal of Pharmacy Practice and Research, researchers from Queensland University of Technology and the University of Queensland in Queensland, Australia, have found that people who take more than four doses of medication each day are more likely to crush tablets or open capsules, thereby possibly decreasing their effectiveness.
Results of the study showed that 44.2% of the 369 respondents believed there would be no issues with crushing tablets or opening capsules.
Researchers also found that 14% said they have trouble swallowing capsules or tablets and that people modified their medicine despite no issues with swallowing. In addition, 10% of respondents reported modifying their medication regardless of how many doses they took each day.
Although the findings found that many participants said they would not ask for advice before modifying their medications or inform their healthcare professional of problems swallowing, previous research has found that healthcare professionals are not asking their patients about swallowing difficulties often enough.
People who take more than four doses of medication each day are more likely to crush tablets or open capsules.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|